12 results
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
- Clinical manifestations ... History: cough, dyspnea ... , Pulmonary lymphoma ... Treatment: • ... ILD #diagnosis #management
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
and Management ... for Klebsiella pneumonia ... Lung Abscess - Clinical ... pain, hemoptysis, dyspnea ... #Abscess #pulmonary
COVID-19 Intubation Checklist

Personal protective equipment (PPE)
 • Standard PPE
   • N95 or PAPR.
COVID-19 Intubation ... Checklist Personal ... Internet Book of Critical ... #Intubation #Checklist ... #SARSCoV2 #Management
Community Acquired Pneumonia (CAP) - Diagnosis and Management

Pneumonia Signs/Symptoms:
 • Confusion/disorientation (LR + 1.9)
 • Cough
Diagnosis and Management ... • Cough • Dyspnea ... aeruginosa Clinical ... in adults with clinically ... #treatment #Pulmonary
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and Pulmonary Thromboendarterectomy
Chronic Thromboembolic Pulmonary Hypertension
Definition: mean pulmonary-artery pressure > 25mmHg
Plexiform-lesion formation Clinical ... Exercise intolerance, dyspnea ... Ventilation-perfusion lung ... Bypass Other Treatment ... Thromboendarterectomy #diagnosis #management
Hepatopulmonary Syndrome - Diagnosis and Management Summary
A defect in arterial oxygenation due to a gas exchange
absence of intrinsic lung ... shunt (Type 2) Clinical ... Presentation: • Dyspnea ... • Platypnea - Dyspnea ... on radioactive lung
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
Amiodarone Induced Lung ... starting amiodarone treatment ... Dyspnea 3. ... macrophages Treatment ... #diagnosis #management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... hemoptysis • Dyspnea ... Tuberculosis Treatment ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... hemoptysis • Dyspnea ... Tuberculosis Treatment ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Cryptogenic Organizing Pneumonia - Illness Script

PATHOPHYSIOLOGY: Unknown trigger, reversible inflammatory/fibroproliferative process. Polypoid fibroblastic aggregates that plug
Symptoms: Cough, dyspnea ... DIAGNOSTICS: Clinical ... , neoplastic) TREATMENT ... #diagnosis #management ... #pulmonary